Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea · Delayed Price · Currency is KRW 1,868.00
0.00 (0.00%)
At close: Jun 30, 2026
Green Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,011 | 110.13 | 1,562 | -16,358 | -3,526 | -3,136 |
Depreciation & Amortization | 773.4 | 789.88 | 768.54 | 2,476 | 2,769 | 2,565 |
Loss (Gain) From Sale of Assets | 0 | 0 | - | - | -1.39 | 2.24 |
Asset Writedown & Restructuring Costs | 1,357 | 1,357 | - | 12,095 | - | - |
Loss (Gain) From Sale of Investments | -1,670 | -1,148 | 144.81 | -43.71 | -694.8 | -416.74 |
Provision & Write-off of Bad Debts | -67.7 | -67.7 | 35.3 | 49.5 | -34.85 | 17.15 |
Other Operating Activities | -944.94 | 246.91 | -1,460 | 693.59 | 1,364 | -369.63 |
Change in Accounts Receivable | -6,522 | -1,944 | -3,500 | 984.56 | 871.71 | -1,716 |
Change in Inventory | -3,344 | -4,456 | 2,187 | 460.55 | -782.87 | 1,270 |
Change in Accounts Payable | 5,543 | 5,461 | 1,409 | -84.25 | -3,276 | 1,277 |
Change in Unearned Revenue | -42.5 | -41.21 | 12.71 | - | 34 | - |
Change in Other Net Operating Assets | -31.66 | 56.08 | -634.36 | 97.1 | -1,274 | 1,118 |
Operating Cash Flow | -1,939 | 363.85 | 525.49 | 370.02 | -4,552 | 611.38 |
Operating Cash Flow Growth | - | -30.76% | 42.02% | - | - | -67.86% |
Capital Expenditures | -894.04 | -859.51 | -780.62 | -495.69 | -1,478 | -3,444 |
Sale of Property, Plant & Equipment | - | - | - | - | 1.5 | 2.1 |
Sale (Purchase) of Intangibles | -606.52 | -300.71 | -60.3 | -10.2 | - | - |
Investment in Securities | 2,024 | 1,205 | 4,143 | 7,791 | 6,489 | 2,948 |
Other Investing Activities | 4.01 | 10.36 | -22.21 | 230.75 | 44.54 | -108.34 |
Investing Cash Flow | 527.44 | 54.79 | 3,280 | 7,516 | 5,057 | -602 |
Short-Term Debt Issued | - | 1,700 | - | 15,753 | 9,552 | 10,128 |
Long-Term Debt Issued | - | 101.06 | - | - | - | - |
Total Debt Issued | 1,801 | 1,801 | - | 15,753 | 9,552 | 10,128 |
Short-Term Debt Repaid | - | - | - | -17,441 | -10,418 | -8,911 |
Long-Term Debt Repaid | - | -180.79 | -189.63 | -221.77 | -205.29 | -256.23 |
Total Debt Repaid | -1,870 | -180.79 | -189.63 | -17,663 | -10,623 | -9,167 |
Net Debt Issued (Repaid) | -69.08 | 1,620 | -189.63 | -1,910 | -1,071 | 961.34 |
Issuance of Common Stock | 2,415 | 2,415 | - | - | - | - |
Repurchase of Common Stock | - | - | -1,657 | -2,366 | - | - |
Other Financing Activities | -102.29 | -127.29 | -82 | -30.84 | 0 | -0 |
Financing Cash Flow | 2,243 | 3,908 | -1,928 | -4,307 | -1,071 | 961.34 |
Foreign Exchange Rate Adjustments | 537.59 | 12.82 | 843.02 | -45.14 | -7.69 | 15.17 |
Net Cash Flow | 1,370 | 4,339 | 2,720 | 3,533 | -573.99 | 985.91 |
Free Cash Flow | -2,833 | -495.66 | -255.13 | -125.67 | -6,030 | -2,832 |
Free Cash Flow Margin | -5.55% | -1.23% | -1.03% | -0.56% | -16.52% | -11.18% |
Free Cash Flow Per Share | -146.14 | -25.82 | -13.26 | -6.30 | -301.49 | -141.61 |
Cash Interest Paid | 275.93 | 209.1 | 234.3 | 226.53 | 163.84 | 18.33 |
Cash Income Tax Paid | - | -6.95 | -55.8 | -69.58 | 83.73 | -0.45 |
Levered Free Cash Flow | -4,064 | -866.81 | -848.11 | 812.18 | -4,933 | -1,743 |
Unlevered Free Cash Flow | -3,921 | -715.46 | -699.32 | 962.45 | -4,862 | -1,730 |
Change in Working Capital | -4,397 | -924.05 | -525.36 | 1,458 | -4,428 | 1,949 |